FDA panel rejects ALS treatment from Brainstorm Cell Therapeutics
September 27, 2023 at 19:36 PM EDT
A U.S. Food and Drug Administration advisory committee voted against a treatment from BrainStorm Cell Therapeutics for amyotrophic lateral sclerosis, or ALS.
